Bone Therapeutics
Biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.
Launch date
Employees
Market cap
€4.3m
Enterprise valuation
€20m (Public information from Nov 2022)
Share price
€0.1 BOTHE.BR
Charleroi Hainaut Province (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Revenues | - | 1.0m | 13.0m | 21.0m |
| % growth | - | - | 1200 % | 62 % |
| EBITDA | (11.0m) | - | (22.0m) | 7.0m |
| % EBITDA margin | - | - | (169 %) | 33 % |
| Profit | (12.0m) | (14.0m) | (3.0m) | 4.0m |
| % profit margin | - | (1400 %) | (23 %) | 19 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€7.7m | Series D | ||
| N/A | €37.0m Valuation: €109m | IPO | |
* | N/A | €19.5m | Post IPO Equity |
€16.0m | Post IPO Debt | ||
* | N/A | €3.3m | Private Placement VC |
| Total Funding | €11.0m | ||
